AJNA BioSciences
Drug Discovery · Health Care
$9Mtotal raised · 2 rounds on record
$2.1Mlatest round · Venture round · May 2024 · 2 yr ago
10+team · employees, estimated range
2021founded
Overview
PIPELINE PLATFORM ABOUT INVESTORS NEWSROOM CONTACT US About At Ajna, we believe in the power of botanicals. Our founders pioneered the CBD industry, setting standards and developing treatments reported to surpass FDA-approved drugs.
Funding and backers
Total raised
$9M
2 rounds on record
Latest round
$2.1M
Venture round · May 2024 · 2 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 28, 2024
Raised a round Venture round $2.1M · SEC Form D
Sep 30, 2021
Raised a round Convertible Note $6.9M · SEC Form D
2021
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | May 2024 | $2.1M | — | SEC Form D |
| Convertible Note | Sep 2021 | $6.9M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | AJNA BioSciences PBC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Joel StanleyExecutive Officer, DirectorSEC Form D
Gregory GouldExecutive OfficerSEC Form D
Scott HumphreysExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About Us Our Approach Our Pipeline Our Platform Resources Press Releases Blog News FAQ For Investors contact us Advancing human health…
Babylon is a drug development company pursuing a transformational treatment for Alzheimer’s. Meet our team and explore how we discover…
We believe every clinical trial should be run twice — first in silico. InSilicoTrials · Est.
Our Mission To develop the world's first FDA-approved drug for acute alcohol intoxication and poisoning. Alcohol consumption can flip in…
Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.
PanTher Therapeutics. PanTher’s technology unleashes the inherent power of cancer-fighting drugs by enabling continuous, high-dose…
People
Joel Stanley
Executive Officer, Director
Gregory Gould
Executive Officer
Scott Humphreys
Executive Officer
Rose Marcario
Director
Jacques Tortoroli
Director
Jesse Stanley
Director
Antony Caracciolo
Director
John Held
Director
Jared Stanley
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
News
Q&A with AJNA's Founder
We sat down with our CEO and Founder, Joel Stanley, to get his perspective on some questions we received from our community. 1. You were the founding CEO of Charlotte's Web, a company that changed the face of CBD. What inspired you to start AJNA BioScienc
Read more
Report
Cutting Through the Noise in Plant Medicine
A Hard Pill to Swallow: Why AJNA Chose the Tougher Road If you've ever walked into a supplement store looking for something to help you sleep, ease your anxiety, or manage pain, you know the overwhelming feeling of standing in front of shelves filled with
Read more
Report
America's Mental Health Needs New Tools
America is hurting. Anxiety, depression, PTSD, addiction, and loneliness have become everyday realities for millions. Emergency rooms are filled with mental health cases. Families are fractured by grief and disconnection. Medications can manage symptoms,
Read more
Report
Psychedelic Science 2025: Lessons From MDMA Trials Could Strengthen Future Psychedelic Approvals Pharmacy Times
Joel Stanley of Ajna Biosciences reflects on the regulatory challenges surrounding MDMA-assisted therapy, outlines lessons for future psychedelic drug trials, and emphasizes the importance of scientific rigor, interdisciplinary infrastructure, and the evo
Read more
Report
Celebrating Sasha Shulgin's 100th with MAPS
Honoring the Godfather of Psychedelics: Sasha Shulgin's 100th Birthday Celebration Fundraiser at Psychedelic Science Last month, amid the powerful current of ideas and breakthroughs flowing through the Psychedelic Science conference, I had the honor of at
Read more
Report
The Kings Of CBD Are Now Cooking Up Plans To Make Billion-Dollar Meds From Cannabis And Mushrooms
Read more
Report
DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
/PRNewswire/ -- DeFloria, Inc., a collaboration between Ajna BioSciences PBC and Charlotte
Read more
Report
DeFloria Announces Positive Results from Phase 1 Trial of AJA001 Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
/PRNewswire/ -- DeFloria, a joint venture between Ajna BioSciences and Charlotte
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Littleton
United States
HQ
10-50 est. staff
8022 Southpark Circle, Suite 500 • Littleton, Colorado 80120